China Cell And Gene Therapy CDMO Market (2025-2031) | Companies, Outlook, Competitive Landscape, Analysis, Growth, Segmentation, Trends, Forecast, Industry, Value, Share, Size & Revenue

Name: China Cell And Gene Therapy CDMO Market (2025-2031) | Companies & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Phase (Pre-clinical, Clinical), By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others) And Competitive Landscape

Product Code: ETC6739156	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

China Cell And Gene Therapy CDMO Market Outlook
Market Size of China Cell And Gene Therapy CDMO Market, 2024
Forecast of China Cell And Gene Therapy CDMO Market, 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Revenues & Volume for the Period 2021- 2031
China Cell And Gene Therapy CDMO Market Trend Evolution
China Cell And Gene Therapy CDMO Market Drivers and Challenges
China Cell And Gene Therapy CDMO Price Trends
China Cell And Gene Therapy CDMO Porter's Five Forces
China Cell And Gene Therapy CDMO Industry Life Cycle
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Phase for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Pre-clinical for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Clinical for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Product Type for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Gene Therapy for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Gene-Modified Cell Therapy for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Cell Therapy for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Indication for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Oncology for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Neurological disorders for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Rare Diseases for the Period 2021- 2031
Historical Data and Forecast of China Cell And Gene Therapy CDMO Market Revenues & Volume By Others for the Period 2021- 2031
China Cell And Gene Therapy CDMO Import Export Trade Statistics
Market Opportunity Assessment By Phase
Market Opportunity Assessment By Product Type
Market Opportunity Assessment By Indication
China Cell And Gene Therapy CDMO Top Companies Market Share
China Cell And Gene Therapy CDMO Competitive Benchmarking By Technical and Operational Parameters
China Cell And Gene Therapy CDMO Company Profiles
China Cell And Gene Therapy CDMO Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 China Cell And Gene Therapy CDMO Market Overview

3.1 China Country Macro Economic Indicators

3.2 China Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F

3.3 China Cell And Gene Therapy CDMO Market - Industry Life Cycle

3.4 China Cell And Gene Therapy CDMO Market - Porter's Five Forces

3.5 China Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.6 China Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 China Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F

4 China Cell And Gene Therapy CDMO Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders in China

4.2.2 Growing investment in cell and gene therapy research and development

4.2.3 Favorable government initiatives and policies supporting cell and gene therapy industry growth in China

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for cell and gene therapy products in China

4.3.2 Limited manufacturing capacity and expertise in cell and gene therapy CDMO sector in China

5 China Cell And Gene Therapy CDMO Market Trends

6 China Cell And Gene Therapy CDMO Market, By Types

6.1 China Cell And Gene Therapy CDMO Market, By Phase

6.1.1 Overview and Analysis

6.1.2 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F

6.1.3 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F

6.1.4 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.2 China Cell And Gene Therapy CDMO Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.3 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F

6.2.4 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.3 China Cell And Gene Therapy CDMO Market, By Indication

6.3.1 Overview and Analysis

6.3.2 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.4 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F

6.3.5 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F

6.3.6 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F

7 China Cell And Gene Therapy CDMO Market Import-Export Trade Statistics

7.1 China Cell And Gene Therapy CDMO Market Export to Major Countries

7.2 China Cell And Gene Therapy CDMO Market Imports from Major Countries

8 China Cell And Gene Therapy CDMO Market Key Performance Indicators

8.1 Number of clinical trials for cell and gene therapy in China

8.2 Investment in cell and gene therapy startups and companies in China

8.3 Number of partnerships and collaborations between international and domestic players in the cell and gene therapy industry in China

9 China Cell And Gene Therapy CDMO Market - Opportunity Assessment

9.1 China Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F

9.2 China Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 China Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F

10 China Cell And Gene Therapy CDMO Market - Competitive Landscape

10.1 China Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024

10.2 China Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Cell And Gene Therapy CDMO Market

Global Cell And Gene Therapy CDMO Market

Middle East Cell And Gene Therapy CDMO Market

North America Cell And Gene Therapy CDMO Market

Russia Cell And Gene Therapy CDMO Market

Saudi Arabia Cell And Gene Therapy CDMO Market

Singapore Cell And Gene Therapy CDMO Market

Slovakia Cell And Gene Therapy CDMO Market

South Africa Cell And Gene Therapy CDMO Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here